Identification of the gene signature reflecting schizophrenia’s etiology by constructing artificial intelligence‐based method of enhanced reproducibility

Abstract

Aims As one of the most fundamental questions in modern science, “what causes schizophrenia (SZ)” remains a profound mystery due to the absence of objective gene markers. The reproducibility of the gene signatures identified by independent studies is found to be extremely low due to the incapability of available feature selection methods and the lack of measurement on validating signatures’ robustness. These irreproducible results have significantly limited our understanding of the etiology of SZ. Methods In this study, a new feature selection strategy was developed, and a comprehensive analysis was then conducted to ensure a reliable signature discovery. Particularly, the new strategy (a) combined multiple randomized sampling with consensus scoring and (b) assessed gene ranking consistency among different datasets, and a comprehensive analysis among nine independent studies was conducted. Results Based on a first‐ever evaluation of methods’ reproducibility that was cross‐validated by nine independent studies, the newly developed strategy was found to be superior to the traditional ones. As a result, 33 genes were consistently identified from multiple datasets by the new strategy as differentially expressed, which might facilitate our understanding of the mechanism underlying the etiology of SZ. Conclusion A new strategy capable of enhancing the reproducibility of feature selection in current SZ research was successfully constructed and validated. A group of candidate genes identified in this study should be considered as great potential for revealing the etiology of SZ.

Identification of differentially expressed genes and their major pathways among the patient with COVID-19, cystic fibrosis, and chronic kidney disease

“…Functional knowledge is arranged and recorded in GO in a way that can be computationally analysed, which is crucial for advanced biomedical research. GO is a computational and statistical method for investigating a group of genes and their biological, molecular, and cellular features, as well as their cell informative pathways [ 24 , 25 ]. Enrichment analysis can be performed on a group of genes identified in genome-wide studies to investigate if they are enriched with genes from a specific pathway or functional category [ 26 ].…”

Construction of the Classification Model Using Key Genes Identified Between Benign and Malignant Thyroid Nodules From Comprehensive Transcriptomic Data

“…The average expression value was retained if one gene was mapped to multiple probes (Yang et al, 2020c). To remove batch effects among five independent datasets, Z-score transformation was used to adjust the gene expression levels in each dataset (Yang Q et al, 2019b;Yang et al, 2020a). Z-score transformation for each gene could be computed by subtracting the mean of all genes and dividing the difference by the standard deviation of all genes in one experiment.…”

Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions

“…In drug discovery studies for schizophrenia, researchers have utilized AI/ML methods with various purposes, including drug target identification, 363,364 developing QSAR models, 365 predicting monitoring dosing compliance, 366 predicting GPCRs targeting compounds, 364 and drug repositioning 367 . Specifically, schizophrenia target genes were identified based on publicly available microarray data sets using an SVM‐RFE (recursive feature elimination)‐based feature selection, where the genes initially ranked by an SVM classifier and the signature was then identified by discarding the genes that were not differentially expressed.…”